By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biodel Inc. 

6 Christopher Columbus Avenue

Danbury  Connecticut  06810-7352  U.S.A.
Phone: 203-798-3600 Fax: 203-798-3601


Drug Delivery

Company News
Albireo (ALBO) Completes Transaction With Biodel (BIOD) To Create Publicly Traded Company Focused On Orphan Pediatric Liver Diseases 11/4/2016 11:19:09 AM
Biodel (BIOD) Announces Adjournment Of Annual Meeting Until Thursday, October 27, Urges Stockholders To Vote 10/25/2016 8:31:57 AM
Biodel (BIOD) Lays Off Another 15 Employees in Restructuring 1/29/2016 10:09:21 AM
Struggling Biodel (BIOD) to Chop 30% of Workforce While Launching and Re-Launching Clinical Trials 11/4/2015 6:17:47 AM
Biodel (BIOD) Announces Removal of Partial FDA Clinical Hold on Phase IIb Study 3-250 10/12/2015 6:18:08 AM
Biodel Inc. (BIOD)'s Insulin Drug Found Effective In Phase 2 Trial 8/11/2014 7:10:35 AM
Biodel Inc. (BIOD) Enters Into $15 Million Equity Commitment With Lincoln Park Capital 7/28/2014 6:52:27 AM
Biodel Inc. (BIOD) To Report Second Quarter Fiscal Year 2014 Financial Results On May 13, 2014 5/8/2014 9:27:51 AM
Biodel Inc. (BIOD) Announces Collaboration Agreement With HEC Pharm for Development of Ultra-Rapid-Acting Insulin Aspart Formulation 4/23/2014 9:05:53 AM
Biodel Inc. (BIOD) Announces Commercial Manufacturing Agreement With Emergent BioSolutions (EBS) For Glucagon Rescue Product 3/6/2014 9:31:11 AM